Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $4.23 Million - $5.64 Million
-30,600 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $3.49 Million - $4.45 Million
30,600 New
30,600 $4.26 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $3.06 Million - $4.7 Million
-40,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$61.52 - $91.1 $2.46 Million - $3.64 Million
40,000 New
40,000 $3.44 Million
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $2.17 Million - $2.78 Million
-30,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$69.46 - $88.57 $2.08 Million - $2.66 Million
30,000 New
30,000 $2.6 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.